British Journal of Cancer - Table of Contents alert Volume 112 Issue 4

TABLE OF CONTENTS Volume 112, Issue 4 (613-776) Published online 17 February 2015 In this issue Minireview Clinical Studies Translational Therapeutics Molecular Diagnostics Genetics and Genomics Also new today Advance online publication Digital Edition MINIREVIEW Top Actin cytoskeletal control during epithelial to mesenchymal transition: focus on the pancreas and intestinal tract H T Morris and L M Machesky Br J Cancer 2015 112: 613-620; advance online publication, January 22, 2015; 10.1038/bjc.2014.658 Abstract | Full Text CLINICAL STUDIES Top Evaluation of chemoresponse assays as predictive markers E L Korn and B Freidlin Br J Cancer 2015 112: 621-623; advance online publication, January 13, 2015; 10.1038/bjc.2014.661 Abstract | Full Text Changes in circulating microRNA-126 during treatment with chemotherapy and bevacizumab predicts treatment response in patients with metastatic colorectal cancer T F Hansen, A L Carlsen, N H H Heegaard, F B Sørensen and A Jakobsen Br J Cancer 2015 112: 624-629; advance online publication, January 13, 2015; 10.1038/bjc.2014.652 Abstract | Full Text Effect of adjuvant trastuzumab among patients treated with anti-HER2-based neoadjuvant therapy A M Gonzalez-Angulo, N Parinyanitikul, X Lei, E A Mittendorf, H Zhang, V Valero, K K Hunt, G N Hortobagyi and M Chavez-MacGregor Br J Cancer 2015 112: 630-635; advance online publication, January 13, 2015; 10.1038/bjc.2014.647 Abstract | Full Text The impact of age on changes in quality of life among breast cancer survivors treated with breast-conserving surgery and radiotherapy E J Bantema-Joppe, G H de Bock, M Woltman-van Iersel, D M Busz, A V Ranchor, J A Langendijk, J H Maduro and E R van den Heuvel Br J Cancer 2015 112: 636-643; advance online publication, January 20, 2015; 10.1038/bjc.2014.632 Abstract | Full Text Phase I/II study of 131I-MIBG with vincristine and 5 days of irinotecan for advanced neuroblastoma S G DuBois, S Allen, M Bent, J F Hilton, F Hollinger, R Hawkins, J Courtier, Y P Mosse and K K Matthay Br J Cancer 2015 112: 644-649; advance online publication, January 20, 2015; 10.1038/bjc.2015.12 Abstract | Full Text A first-in-human phase I, dose-escalation, multicentre study of HSP990 administered orally in adult patients with advanced solid malignancies A Spreafico, J-P Delord, L De Mattos-Arruda, Y Berge, J Rodon, E Cottura, P L Bedard, M Akimov, H Lu, S Pain, A Kaag, L L Siu and J Cortes Br J Cancer 2015 112: 650-659; advance online publication, January 27, 2015; 10.1038/bjc.2014.653 Abstract | Full Text Surgical staging and prognosis in serous borderline ovarian tumours (BOT): A subanalysis of the AGO ROBOT study F Trillsch, S Mahner, E Vettorazzi, L Woelber, A Reuss, K Baumann, M-D Keyver-Paik, U Canzler, K Wollschlaeger, D Forner, J Pfisterer, W Schroeder, K Muenstedt, B Richter, C Fotopoulou, B Schmalfeldt, A Burges, N Ewald-Riegler, N de Gregorio, F Hilpert, T Fehm, W Meier, P Hillemanns, L Hanker, A Hasenburg, H-G Strauss, M Hellriegel, P Wimberger, S Kommoss, F Kommoss, S Hauptmann and A du Bois Br J Cancer 2015 112: 660-666; advance online publication, January 6, 2015; 10.1038/bjc.2014.648 Abstract | Full Text Self-sampling to increase participation in cervical cancer screening: an RCT comparing home mailing, distribution in pharmacies, and recall letter P Giorgi Rossi, C Fortunato, P Barbarino, S Boveri, S Caroli, A Del Mistro, A Ferro, C Giammaria, M Manfredi, T Moretto, A Pasquini, M Sideri, M C Tufi, C Cogo, E Altobelli and the HPV Self-sampling Italian Working Group Br J Cancer 2015 112: 667-675; advance online publication, January 29, 2015; 10.1038/bjc.2015.11 Abstract | Full Text Impact of investigations in general practice on timeliness of referral for patients subsequently diagnosed with cancer: analysis of national primary care audit data G P Rubin, C L Saunders, G A Abel, S McPhail, G Lyratzopoulos and R D Neal Br J Cancer 2015 112: 676-687; advance online publication, January 20, 2015; 10.1038/bjc.2014.634 Abstract | Full Text TRANSLATIONAL THERAPEUTICS Top BRCA1 haplotype and clinical benefit of trabectedin in soft-tissue sarcoma patients A Laroche-Clary, V Chaire, V Le Morvan, A Neuville, F Bertucci, S Salas, R Sanfilippo, P Pourquier and A Italiano Br J Cancer 2015 112: 688-692; advance online publication, January 20, 2015; 10.1038/bjc.2014.624 Abstract | Full Text Cell migration in paediatric glioma; characterisation and potential therapeutic targeting J V Cockle, S Picton, J Levesley, E Ilett, A M Carcaboso, S Short, L P Steel, A Melcher, S E Lawler and A Brüning-Richardson Br J Cancer 2015 112: 693-703; advance online publication, January 27, 2015; 10.1038/bjc.2015.16 Abstract | Full Text ACTN4 copy number increase as a predictive biomarker for chemoradiotherapy of locally advanced pancreatic cancer T Watanabe, H Ueno, Y Watabe, N Hiraoka, C Morizane, J Itami, T Okusaka, N Miura, T Kakizaki, T Kakuya, M Kamita, A Tsuchida, Y Nagakawa, H Wilber, T Yamada and K Honda Br J Cancer 2015 112: 704-713; advance online publication, January 20, 2015; 10.1038/bjc.2014.623 Abstract | Full Text MOLECULAR DIAGNOSTICS Top Nutrient stress alters the glycosylation status of LGR5 resulting in reduced protein stability and membrane localisation in colorectal tumour cells: implications for targeting cancer stem cells R G Morgan, E Molnár, R F Jones, T J Collard, J D Lane, A Greenhough, C Paraskeva and A C Williams Br J Cancer 2015 112: 714-719; advance online publication, January 22, 2015; 10.1038/bjc.2015.4 Abstract | Full Text KRAS and BRAF mutations are prognostic biomarkers in patients undergoing lung metastasectomy of colorectal cancer S Renaud, B Romain, P-E Falcoz, A Olland, N Santelmo, C Brigand, S Rohr, D Guenot and G Massard Br J Cancer 2015 112: 720-728; 10.1038/bjc.2014.499 Abstract | Full Text Nuclear osteopontin-c is a prognostic breast cancer marker K Zduniak, P Ziolkowski, C Ahlin, A Agrawal, S Agrawal, C Blomqvist, M-L Fjällskog and G F Weber Br J Cancer 2015 112: 729-738; advance online publication, January 27, 2015; 10.1038/bjc.2014.664 Abstract | Full Text High-temperature-required protein A2 as a predictive marker for response to chemotherapy and prognosis in patients with high-grade serous ovarian cancers M Miyamoto, M Takano, K Iwaya, N Shinomiya, T Goto, M Kato, A Suzuki, T Aoyama, J Hirata, I Nagaoka, H Tsuda and K Furuya Br J Cancer 2015 112: 739-744; advance online publication, January 27, 2015; 10.1038/bjc.2015.1 Abstract | Full Text Mesenchymal stem cells are enriched in head neck squamous cell carcinoma, correlates with tumour size and inhibit T-cell proliferation F Liotta, V Querci, G Mannelli, V Santarlasci, L Maggi, M Capone, M C Rossi, A Mazzoni, L Cosmi, S Romagnani, E Maggi, O Gallo and F Annunziato Br J Cancer 2015 112: 745-754; advance online publication, February 3, 2015; 10.1038/bjc.2015.15 Abstract | Full Text Early Growth Response 3 regulates genes of inflammation and directly activates IL6 and IL8 expression in prostate cancer V T Baron, R Pio, Z Jia and D Mercola Br J Cancer 2015 112: 755-764; advance online publication, January 29, 2015; 10.1038/bjc.2014.622 Abstract | Full Text GENETICS AND GENOMICS Top Low-level constitutional mosaicism of a de novoBRCA1 gene mutation E Friedman, N Efrat, L Soussan-Gutman, A Dvir, Y Kaplan, T Ekstein, K Nykamp, M Powers, M Rabideau, J Sorenson and S Topper Br J Cancer 2015 112: 765-768; advance online publication, January 29, 2015; 10.1038/bjc.2015.14 Abstract | Full Text Circulating leukocyte telomere length and risk of overall and aggressive prostate cancer B Julin, I Shui, C M Heaphy, C E Joshu, A K Meeker, E Giovannucci, I De Vivo and E A Platz Br J Cancer 2015 112: 769-776; advance online publication, January 6, 2015; 10.1038/bjc.2014.640 Abstract | Full Text